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Abstract
Introduction: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality in the world. 
Systematic treatment of COPD decreases symptoms and reduces the frequency of exacerbations and hospitalisations because 
of the disease. It is estimated that only 50% of patients use prescribed drugs systematically. The aim of this study was to identify 
the factors which can influence adherence to treatment of the patients who were treated due to exacerbation of COPD. 
Material and methods: A questionnaire probe was conducted on 49 patients hospitalised at the Regional Lung and Tuberculosis 
Hospital in Olsztyn, Poland due to COPD exacerbation. The assessed variables were: quality of life and adherence to treatment 
30 days after discharge from hospital in relationship with demographic factors, social status, disease and hospitalisation course, 
and relief after systematic treatment.
Results: Most of the patients assessed their health condition as poor and the disease as limiting their everyday social and oc-
cupational activity. 30 days after discharge from hospital the adherence rate to therapy was only 67%. There was an association 
between systematic treatment and the rate of exacerbations (P = 0.045) and hospitalisations (P = 0.005) but also clinical benefit 
after long-term treatment (P = 0.023). There were no associations between adherence to treatment and sex, place of residence, 
education or occupation.
Conclusions: Lack of systematic treatment is the main risk factor for COPD exacerbations and hospitalisation rate. A subjective 
sense of relief after drugs is a factor improving patients’ compliance. 
Key words: COPD, adherence, demographic factors 
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Streszczenie
Wstęp: Przewlekła obturacyjna choroba płuc (POChP) jest jedną z najczęstszych przyczyn chorobowości i umieralności na świe-
cie. Regularne leczenie pozwala na zmniejszenie nasilenia objawów, a także częstości zaostrzeń i hospitalizacji z powodu choroby. 
Jednak jedynie około 50% pacjentów przyjmuje regularnie przepisane leki. Celem pracy była ocena czynników wpływających na 
stosowanie się chorych na POChP, u których doszło do zaostrzenia choroby, do zaleceń lekarskich.
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Materiał i metody: Badaniem ankietowym objęto 49 pacjentów hospitalizowanych w Samodzielnym Publicznym Zespole Gruźlicy 
i Chorób Płuc w Olsztynie z powodu zaostrzenia POChP. Oceniano jakość życia, i stosowanie się do zaleceń lekarskich 30 dni po 
wypisie ze szpitala w zależności od czynników demograficznych, statusu społecznego, przebiegu choroby i hospitalizacji, a także 
poprawy odczuwanej po stosowanym leczeniu. 
Wyniki: Większość chorych oceniła swój stan zdrowia jako zły, a chorobę jako ograniczającą codzienną aktywność społeczną 
i zawodową. Trzydzieści dni po hospitalizacji zalecenia lekarskie wypełniało ściśle jedynie 67% badanych. Wykazano związek 
pomiędzy systematycznością leczenia a częstością zaostrzeń POChP (p = 0.045) i hospitalizacji (p = 0.005) oraz odczuwaniem 
poprawy po stosowanym leczeniu (p = 0.023). Płeć, miejsce zamieszkania, wykształcenie, a także rodzaj wykonywanej pracy 
nie miały związku ze stosowaniem się do zaleceń lekarskich. 
Wnioski: Czynnikiem mającym największy wpływ na częstość zaostrzeń i hospitalizacji jest systematyczność leczenia. Odczuwa-
nie przez chorych subiektywnej poprawy po lekach poprawia współpracę pomiędzy lekarzem i pacjentem. 
Słowa kluczowe: POChP, stosowanie się do zaleceń, czynniki demograficzne
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Introduction
Chronic obstructive pulmonary disease 
(COPD) is one of the most frequent causes of 
chronic morbidity and mortality in the world. 
It poses a serious problem to public health, and 
it is a frequent cause of hospitalisation and early 
disability of patients. It is estimated that curren-
tly in Poland about 2 million people suffer from 
COPD [1–4]. It is likely that in 2020 COPD will be 
the third cause of death worldwide [5].
COPD is a progressive disease which is di-
stinguished by permanent limitations of airflow 
through the respiratory tract. Chronic symptoms 
deteriorate the quality of life and limit the oc-
cupational and social lives of patients [2, 6–9]. 
In a natural course of COPD there are periods of 
exacerbations that, additionally, deteriorate the 
quality of life, precipitate decrease in ventilation 
parameters, and increase mortality rate [2, 10–12]. 
Despite the irreversible nature of some chan-
ges, COPD is a disease which may be treated effec-
tively. It has been proven that many therapeutic 
strategies not only allow the control of symptoms 
and improve patients’ quality of life, but also de-
crease the intensity and duration of exacerbations 
and the frequency of hospitalisations due to the 
disease [2, 10, 13, 14]. However, it is necessary to 
undergo systematic and appropriate treatment. 
Meanwhile, the studies conducted in different 
countries have shown that although in clinical stu-
dies patients take 70–90% of prescribed drug doses 
[15–18], only 50% of patients adhere to medical 
recommendations in everyday practice [19–22]. 
The factors that influence adherence to re-
commended treatment in COPD patients are 
unknown. Knowledge about them could improve 
the cooperation between the patient and doctor, 
and consequently improve control of the disease. 
The objective of the study was to evaluate 
factors that influence adherence to treatment in 
COPD patients who underwent exacerbations of 
the disease.
Material and methods
A questionnaire probe included patients with 
previously diagnosed COPD, hospitalised due to 
exacerbation of the disease at the Regional Lung 
and Tuberculosis Hospital in Olsztyn in the pe-
riod from November 2009 until March 2010. The 
SF-36 questionnaire [23] concerning physical, 
mental and social aspects enabled the assess-
ment patients’ quality of life, self-assessment 
of their health condition and impact of COPD 
on occupational and social activity. With the 
help of questionnaires created by the authors 
and information provided by the patients, we 
gathered demographic data and information 
concerning cigarette smoking. We also evalu-
ated the influence of the disease on everyday 
life, the frequency of exacerbations and hospi-
talisations, and the impact of hospitalisation 
and applied drugs on improvement of patients’ 
health condition. Furthermore, 30 days after 
discharge from hospital, based on telephone 
conversations, we assessed patients’ adherence 
to recommended treatment in relation to the 
above-mentioned variables. 
The study included 49 patients (26 male and 
23 female) in the age range 47-83 years (mean 
age 63.7 ± 7.1 years), inhabitants of villages, 
towns and cities. The majority of respondents 
lived with family or spouse; only 6% of patients 
declared living alone (Table 1). Most patients 
received elementary education (43%) or vocatio-
nal secondary education (25%). 22% of patients 
acquired secondary education, and 10% — higher 
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Table 1. Characteristics of the study group
Tabela 1. Charakterystyka badanej grupy
Characteristic Percentage 
(number)
Place of residence 
— village
— city < 20,000 inhabitants
— city > 20,000 inhabitants
33 (16)
37 (18)
30 (15)
Family status
— living with family
— living with spouse
— living alone
— others
37 (18)
55 (27)
6 (3)
2 (1)
The sources of patients knowledge about chronic 
obstructive pulmonary disease
— pulmonologist
— general practitioner
— nurse
— other patients
— brochure
— internet
74 (36)
82 (40)
10 (5)
18 (9)
10 (5)
10 (5)
Duration of present hospitalisation
— ≥ 7 days
— 8–14 days
— 15–21 days
— > 21 days
6 (3)
49 (24)
43 (21)
2 (1)
The numer of past hospitalisations
— 1–4 
— 5–8 
— > 8 
57 (28)
31 (15)
12 (6)
education. 20% of respondents were white-collar 
workers and 33% of them were manual workers. 
Unemployed patients constituted 47% of the 
study group.
29% of respondents were never-smokers, and 
49% of them smoked cigarettes in the past. 22% 
of patients were current cigarette smokers, and 
55% of them smoked more than 20 cigarettes per 
day. The majority of cigarette smokers (91%) had 
tried to give up smoking in the past, and 91% of 
them declared their readiness to give up smoking 
in the future. 
74% of respondents have never participated 
in training in COPD. Their source of information 
about the disease was usually from attending 
physicians. 10% of them declared that they 
acquired their knowledge from the Internet 
(Table 1).
Most of the patients were hospitalised for 
longer than 7 days, and 43% of them were in 
hospital for 15–21 days. For many patients it was 
not their first stay in hospital; 43% of respondents 
were hospitalised due to COPD five or more times 
(Table 1). 
The studies obtained the approval of the local 
ethics committee NKEBN/604/2001.
Table 2. A self-assessment of patients’ health status
Tabela 2. Samoocena stanu zdrowia chorych
Characteristic Percentage 
(number)
A health status
— excellent
— good
— fairly good
— poor
2  (1)
10 (5)
29 (14)
59 (29)
Health status compared to that from the previous year
— much better
— somewhat better
— about the same
— somewhat worse
— much worse
4 (2)
2 (1)
31 (15)
31 (15)
33 (16) 
The influence of physical health or emotional pro-
blems on social activities
— not at all
— slight
— moderate
— quite a big
— extreme
2 (1)
12 (6)
31 (15)
25 (12)
31 (15)
Improvement after hospitalisation
— yes
— not 
— I don’t know
88 (43)
4 (2)
8 (4)
Improvement after treatment
— yes
— not 
— I don’t know
69 (34)
12 (6)
18 (9)
Statistical analysis
The collected data were statistically analysed 
with the help of statistical program SPSS vs. 14. 
To evaluate significance of differences between the 
variables, the chi-square test was used. P < 0.05 
was assumed as the level of statistical significance. 
Results
The vast majority of subjects evaluated their 
health condition as poor. Only 12% of respon-
dents evaluated it as good or very good. Moreover, 
most of the patients believed that their health had 
deteriorated during the previous year (Table 2). 
In the patients’ opinion, the disease had 
hindered, to various degrees, typical activities of 
their everyday life. The most arduous for patients 
is ascending stairs up several storeys, as well as 
activities that require some effort or longer walks 
(Table 3). As much as 88% of respondents admit-
ted that their health condition caused difficulties 
while doing their job or other activities, limited 
the type of such activities (90%), led to shortened 
time spent on them (82%) and prevented them 
from achieving their aspirations (90%). In the pa-
tients’ opinion, although emotional health did not 
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Table 3. The structure of the study group of chronic obs-
tructive pulmonary disease symptoms patients 
according to difficulties in performing typical 
everyday activities
Tabela 3. Struktura badanej grupy pacjentów chorych na 
przewlekłą obturacyjną chorobę płuc według 
trudności w wykonywaniu typowych czynności 
dnia codziennego
Activities Yes,  
limits  
a lot
Yes, 
limits  
a little
No, 
doesn’t 
limit  
at all
Vigorous activities 80% 18% 2%
Moderate activities 53% 41% 6%
Carrying groceries 45% 43% 12%
Climbing several flights  
of stairs
90 10% 0%
Climbing one flight of stairs 43% 47% 10%
Bending or kneeling 45 41% 14%
Walking more than 1 km 71% 22% 6%
Walking about 500 m 39% 39% 22%
Walking about 100 m 27% 27% 47%
Bathing or dressing yourself 39% 27% 35%
influence the accuracy of the performed work, it 
limited the amount of time spent on work or other 
activities (72%) and prevented the patients from 
achieving their aspirations (8%). The majority 
of respondents believed that their physical and 
emotional health had an adverse impact on their 
social activity with family, friends, neighbours 
and other people (Tables 2 and 3). 
During discharge from hospital, 88% of 
patients admitted that hospitalisation resulted 
in an improvement in their health, and 69% of 
patients said that the applied treatment reduced 
the symptoms of the disease. However, 18% of 
respondents were not able to state whether the 
applied treatment resulted in an improvement 
in their health, and 12% of them claimed that 
alleviation of symptoms did not occur (Table 2).
During discharge from hospital, patients 
received guidelines on further use of drugs. All 
patients admitted that the guidelines were fully 
understandable.
During telephone conversations conducted 
30 days after discharge from hospital, the vast 
majority (90%) of respondents still believed that 
hospitalisation improved their health. Most of 
the patients were under supervision of a pneumo-
logist or allergist (69%) and 27% were under 
supervision of a general practitioner.
The majority of respondents (96%) declared 
that they followed medical recommendations 
given during discharge from hospital. The re-
maining 4% of patients had prescribed drugs 
changed by an attending physician. 55% of the 
patients who had declared a desire to stop smo-
king during discharge from hospital achieved the 
objective after 30 days.
One month after discharge from hospital, 
67% of respondents said that they were taking 
drugs in accordance with medical recommenda-
tions, and 10% admitted that they were taking 
drugs systematically but that they did not obey 
medical recommendations precisely. Every fi-
fth respondent (20%) admitted taking drugs in 
case of exacerbation of the disease, and 2% of 
respondents could not declare that they adhered 
to treatment.
We have shown a significant correlation 
between patients’ adherence to recommended 
treatment and number of exacerbations of the 
disease during the preceding year (P = 0.045). 
The patients who underwent exacerbation of 
the disease from 1 to 5 times were taking drugs 
systematically. Among patients who underwent 
exacerbation more than 10 times, the majority 
were persons who took drugs only in case of 
exacerbations (Fig. 1).
We have also shown a correlation between 
the number of hospitalisations and the regularity 
of taking drugs (P < 0.005). The patients who 
were more often hospitalised took drugs only 
during COPD exacerbations significantly more 
frequently. The patients who were taking drugs 
systematically and in accordance with medical 
Figure 1. The structure of the study group according to the use of 
prescribed drugs in relation to the number of chronic obstructive 
pulmonary disease symptoms exacerbations per year
Rycina 1. Struktura badanej grupy według stosowania zaleconych le-
ków w zależności od liczby zaostrzeń przewlekłej obturacyjnej choroby 
płuc w ciągu roku
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Figure 3. The structure of the study group according to the use of 
prescribed drugs in relation to reported release of chronic obstructive 
pulmonary disease symptoms after treatment
Rycina 3. Struktura badanej grupy według stosowania zaleconych 
leków w zależności od zgłaszanego złagodzenia objawów przewlekłej 
obturacyjnej choroby płuc po stosowaniu leczenia
Figure 2. The structure of the study group according to the use of 
prescribed drugs in relation to the number of past hospitalisations
Rycina 2. Struktura badanej grupy według stosowania zaleconych 
leków w zależności od liczby przebytych hospitalizacji
Table 4. Adherence to medical recommendations in chronic obstructive pulmonary disease patients in relation to demo-
graphic features
Tabela 4. Stosowanie się pacjentów z przewlekłą obturacyjną chorobą płuc do zaleceń lekarskich w zależności od cech 
demograficznych
Characteristic According  
to recommendations
Not according  
to recommendations, 
but systematically
Only in disease  
exacerbations 
I don’t know
Sex
— females
— males
74% (17)
62% (16)
9% (2)
12% (3)
17% (4)
23% (6)
0% (0)
4% (1)
Education
— primary
— vocational
— secondary
— higher
71% (15)
50% (6)
82% (9)
60% (3)
5% (1)
17% (2)
9% (1)
20% (1)
24% (5)
25% (3)
9% (1)
20% (1)
0% (0)
8% (1)
0% (0)
0% (0)
Place of residence
— country
— city < 20,000 inhabitants
— city > 20,000 inhabitants
63% (10)
67% (12)
73% (11)
6% (1)
11% (2)
13% (2)
31% (5)
17% (3)
13% (2)
0% (0)
6% (1)
0% (0)
Type of occupation
— manual work
— office work
— unemployed
56% (9)
70% (7)
74% (17)
0% (0)
10% (1)
17% (4)
38% (6)
20% (2)
9% (2)
6% (1)
0% (0)
% (0)
recommendations had undergone fewer hospita-
lisations in the past (Fig. 2). 
The regularity of taking drugs depended on 
the assessment of the positive impact of the drugs 
in alleviating symptoms of the disease (P = 0.023). 
The patients who observed a positive impact of 
treatment on their health had adhered to medical 
recommendations more frequently. The persons 
who did not observe improvement, more frequ-
ently had taken prescribed drugs only in case of 
exacerbation of the disease (Fig. 3).
No correlation was found between the stu-
died demographic features and the regularity of 
taking drugs. No correlation was found between 
degree of adherence to treatment and sex, place 
of residence, education or type of occupation. 
Demographic data are presented in Table 4.
Discussion
Chronic obstructive pulmonary disease is 
one of the most frequent causes of morbidity 
and mortality in the world, and its prevalence is 
constantly growing. Treatment of the disease is 
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a considerable burden to healthcare systems, and 
treatment of exacerbations of the disease is the 
most expensive, particularly if the patient needs 
to be hospitalised [2, 3, 5, 10, 24]. Exacerbations 
that are experienced by the patient from 0.5 to 
3.5 times per year [25] worsen the quality of life 
and ventilation parameters, and increase morta-
lity [11, 24, 26]. One factor associated with poor 
prognosis is unsatisfactory cooperation between 
the patient and doctor. The results of the study 
indicate that regularity of treatment is a factor that 
has a positive effect on reduction of frequency of 
exacerbations and hospitalisations. On the other 
hand, the patient’s feeling that his/her health 
ameliorated is a factor that improves cooperation 
between the patient and doctor.
Appropriate treatment of COPD may reduce 
clinical symptoms, frequency and severity of 
exacerbations and hospitalisations. It also im-
proves the exercise tolerance and general health 
condition of patients [13, 14, 18, 25, 27–29]. The-
refore, it seems obvious that failure to regularly 
treat COPD deteriorates the course of the disease 
and increases mortality rate, which has also been 
shown in the research [12, 16, 18, 22, 30].
Unfortunately, applicable standards are often 
forgotten during treatment [20, 31–35]. Further-
more, many patients do not adhere to medical 
recommendations concerning taking drugs or 
non-pharmacological treatment [19, 34, 36]. In 
the present study, 67% of patients adhered to 
treatment, and next 10% of patients were taking 
drugs systematically, whereas in numerous exa-
mined populations drugs were taken regularly 
only by approximately 50% of subjects [20–22, 
36, 37]. The relatively high proportion of coope-
rating patients in the study population, compared 
to other research projects, may be caused by the 
short period of time (30 days) between discharge 
from hospital and evaluation in the questionnaire. 
It is known that adherence to treatment is at its 
best shortly after a doctor’s appointment, and it 
becomes weaker as time goes by [15, 30, 38].
There are various reasons why patients do 
not adhere to treatment. Some patients omit drug 
doses unintentionally, because they forget, espe-
cially when they feel well or they are distracted 
by other activities, or when they misunderstood 
medical recommendations. Others do it inten-
tionally, e.g. due to high costs of the therapy or 
when they have achieved certain clinical impro-
vement. Some patients stop the therapy when the 
drug prescribed during a doctor’s appointment 
finishes. However, patients rarely omit drug doses 
due to its adverse effects [16, 19, 33, 39, 40].
Attempts to assess whether adherence to 
treatment is influenced by demographic factors 
brought divergent results. Whereas in one study 
women followed medical recommendations better 
[41], in others, similarly as in the present study, 
such differences were not found [16, 22, 40]. 
Patient age was not a factor that allowed pre-
diction of adherence to treatment either. It has 
been shown that in some populations the elderly 
demonstrated better cooperation [15, 16, 21]; 
however, it has not been confirmed by other 
analyses [22, 42].
It could be expected that better adherence 
to treatment would be presented by educated 
patients who understand the need for regular 
treatment of the disease. However, we did not 
find any relation with education or occupation. 
There was no relation with place of residence or 
family situation either. Other studies have not 
shown unambiguous results. Some authors have 
proved that better adherence to treatment is ob-
served in more educated patients [21] and those 
who are married [15, 21], and others did not find 
dependence between the level of cooperation of 
the patient and his/her social status, marital status 
or employment [22]. 
Divergences noted in particular studies might 
depend on different affluence of patients. Howe-
ver, the price of a drug is not always decisive in 
relation to the patient’s adherence to recommen-
ded treatment. Agh et al. showed that patients 
adhered to treatment poorly when they had se-
veral drugs prescribed, but the price of the drugs 
did not influence their attitude to treatment [16].
It seems that patients with more severe forms 
of COPD and a larger number of clinical symp-
toms should adhere to treatment more precisely. 
Such dependence has been confirmed by J. Tur-
ner [21]. According to her, in a study group of 
COPD patients, those with lower FEV1 and larger 
dyspnoea intensification followed medical recom-
mendations more precisely. However, in other 
groups of patients these dependences were not so 
indisputable. Although in the study conducted by 
Rand, patients with lower FEV1 values cooperated 
better, they suffered from smaller dyspnoea inten-
sification [15]. In research by other authors, no 
dependence was found between adherence to tre-
atment and severity of the disease [16, 40]; even 
patients with more severe forms of the disease, 
lower FEV1 values and bigger dyspnoea intensifi-
cation adhered to treatment to a lesser degree [18, 
30]. In the research by Corden, no dependence 
was shown between adherence to treatment and 
quality of life, although the latter deteriorated 
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significantly during 4 weeks of observation in 
patients who followed recommendations only to 
some degree [22]. 
In the present study, patients with more 
frequent exacerbations of COPD and past hospita-
lisations, so probably with the most severe forms 
of the disease, adhered to treatment less accura-
tely. Simultaneously, according to the results of 
the study by Rand et al., the patients who follo-
wed medical recommendations best were more 
rarely hospitalised [15]. The researches by other 
authors have also shown that the patients who 
followed recommendations more precisely had 
fewer exacerbations of COPD and hospitalisations 
per year [18, 30]. On the other hand, it is known 
that chronic, regular treatment of COPD reduces 
the number of exacerbations and hospitalisations 
[13, 14]. Therefore, it may be presumed that the 
reason for poor cooperation of patients was not 
the severity of the disease, but irregular taking 
of drugs, which favoured a greater number of 
exacerbations and hospitalisations. 
However, the present study has shown that 
patients who observed positive effects of the 
therapy cooperated better, which has also been 
confirmed by other researches [19, 43].
Restrepo has proven that non-adherence to 
treatment may be caused by a large number of pre-
scribed drugs, often with different dosage schedu-
les [19]. It should be emphasised that COPD 
patients often suffer from numerous concomitant 
diseases that also need to be treated pharmacolo-
gically. A complicated dosage schedule of a large 
number of drugs creates favourable conditions to 
omit drug doses or intentionally modify medical 
recommendations. Although in some research 
projects, dependence between the number of 
prescribed drugs and adherence to treatment was 
not shown [22, 37, 41], other studies found that 
such a dependence may exist [16]. Dosage form 
is also of crucial importance. Some patients find 
the use of drugs via inhaler problematic [19, 43]. 
Therefore, it seems to be necessary to discuss with 
the patient the symptoms that are his/her most 
problematic ailment caused by COPD. Working 
out a treatment plan together directed at reduc-
tion of the patient’s subjective ailments may be 
the solution to improve cooperation between the 
patient and the doctor.
The majority of the examined patients ob-
served a reduction of symptoms after hospita-
lisation, but also as the result of chronic use of 
prescribed drugs. Nevertheless, 30 days after 
discharge from hospital many of them ceased 
following medical recommendations. It is pos-
sible that such an attitude is connected with 
poor awareness or knowledge about the disease 
[16, 19]. It has been repeatedly proven that COPD 
patients cooperate better when they know the 
pathogenesis of the disease and the available 
therapeutic modalities. Confidence in the doctor 
and in the efficacy of prescribed drugs are also 
of great importance [19, 37, 42, 44]. In the past 
it has also been shown that some problems with 
adherence to treatment are encountered with 
patients who smoke cigarettes, despite the fact 
that this addiction has a negative effect on the 
clinical course of the disease [16, 21]. It may also 
be connected with poor awareness and knowledge 
about COPD in this group of patients [16]. 
Only 27% of patients in the present paper 
participated in training in COPD in the past. Bet-
ter knowledge may significantly improve patients’ 
adherence to treatment, reduce the number of 
exacerbations of the disease and ameliorate the 
quality of life. In particular, understanding the 
objectives of treatment, the mechanisms of drugs’ 
activity and repeated training in inhalation tech-
niques may be of vital importance [17, 19, 45, 46].
Appropriately systematised educational ma-
terial could be spread via the Internet. By visiting 
websites and educational platforms, patients can 
take advantage of easily accessible information 
that is often in a multimedia form, and they can 
share their experience with other patients. Every 
tenth patient from the present study had used the 
Internet to find information about the disease, 
and in the future this proportion will probably 
be higher.
In the past it has been proven that patients 
who have some knowledge about the disease co-
operate well with their doctor, even if they have 
many prescribed drugs [37]. Furthermore, when 
the patient learns how to manage on his/her own 
in the case of COPD exacerbations, it results in 
a reduction in their number and duration, and 
improves control of the disease [10, 17, 46].
The disadvantage of the present paper is the 
relatively small number of patients included in 
the study. This was due to the short duration 
of the study and the fact that it included only 
patients whose available medical documenta-
tion confirmed COPD diagnosed in the past by 
a pulmonologist or allergist, or during the patient’s 
stay at the lung diseases ward. Due to the fact 
that the reason for current hospitalisation was 
exacerbation of COPD, spirometry was not perfor-
med. Unfortunately, most patients did not have in 
their documentation on spirometry results from 
the past; therefore, determination of the stage of 
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the disease based on obstruction intensification 
was not possible. But based on past exacerbations 
and hospitalisations reported by patients, and 
according to currently applicable classification, 
the majority of patients could be classified as class 
C and D of obstructive pulmonary disease [7].
Conclusions
Non-adherence to treatment in patients with 
COPD results in more frequent exacerbations 
of the disease and hospitalisations. However, 
clinical improvement after applied treatment 
improves cooperation between the patient and 
doctor. Nevertheless, only 67% of patients take 
prescribed drugs regularly. Sex, place of resi-
dence, education or kind of occupation do not 
influence adherence to treatment. 
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